C J Glueck, R I Levy, D S Fredrickson. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Acetates/pharmacologyAcetates/therapeutic useAdolescentAdultBlood Protein Disorders/diagnosisBlood Protein Disorders/drug therapyBlood Protein Disorders/enzymologyBlood Protein Disorders/metabolismDietElectrocardiographyElectrophoresisFatty Acids, Nonesterified/bloodFemaleGlucose Tolerance TestHeparin/pharmacologyHumansHydrolases/bloodHyperlipidemias/drug therapyHyperlipidemias/enzymologyHyperlipidemias/geneticsHyperlipidemias/metabolismHypoglycemic Agents/therapeutic useInsulin/bloodLipase/bloodLipid MetabolismLipoproteins/bloodMaleMiddle AgedMyocardial Infarction/complicationsNorethindrone/administration & dosageNorethindrone/pharmacologyNorethindrone/therapeutic usePancreatitis/complicationsSex FactorsTriglycerides/blood
Substances: See more » AcetatesFatty Acids, NonesterifiedHypoglycemic AgentsInsulinLipoproteinsTriglyceridesHeparinHydrolasesLipaseNorethindrone
Year: 1971 PMID: 5568147 DOI: 10.7326/0003-4819-75-3-345
Source DB: PubMed Journal: Ann Intern Med ISSN: 0003-4819 Impact factor: 25.391